[HTML][HTML] Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and …

A Bhadhuri, P Kind, P Salari, KT Jungo… - Health and quality of life …, 2020 - Springer
Abstract Background The EQ-5D-3L and EQ-5D-5L are two generic health-related quality of
life measures, which may be used in clinical and health economic research. They measure …

[PDF][PDF] Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy

A Bhadhuri, P Kind, P Salari, KT Jungo, B Boland… - 2020 - academia.edu
Abstract Background: The EQ-5D-3L and EQ-5D-5L are two generic health-related quality of
life measures, which may be used in clinical and health economic research. They measure …

Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy

A Bhadhuri, P Kind, P Salari, KT Jungo… - Health and quality of …, 2020 - edoc.unibas.ch
Background: The EQ-5D-3L and EQ-5D-5L are two generic health-related quality of life
measures, which may be used in clinical and health economic research. They measure …

Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy.

A Bhadhuri, P Kind, P Salari, KT Jungo… - Health and quality of …, 2020 - boris.unibe.ch
BACKGROUND The EQ-5D-3L and EQ-5D-5L are two generic health-related quality of life
measures, which may be used in clinical and health economic research. They measure …

Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy

A Bhadhuri, P Kind, P Salari, KT Jungo… - Health and Quality …, 2020 - eprints.whiterose.ac.uk
Background The EQ-5D-3L and EQ-5D-5L are two generic health-related quality of life
measures, which may be used in clinical and health economic research. They measure …

[PDF][PDF] Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy

A Bhadhuri, P Kind, P Salari, KT Jungo, B Boland… - 2020 - researchinformation.umcutrecht.nl
Abstract Background: The EQ-5D-3L and EQ-5D-5L are two generic health-related quality of
life measures, which may be used in clinical and health economic research. They measure …

[PDF][PDF] Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy

A Bhadhuri, P Kind, P Salari, KT Jungo, B Boland… - 2020 - scholar.archive.org
BACKGROUND The EQ-5D-3L and EQ-5D-5L are two generic health-related quality of life
measures, which may be used in clinical and health economic research. They measure …

Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy.

A Bhadhuri, P Kind, P Salari, KT Jungo… - Health and Quality of …, 2020 - go.gale.com
Background The EQ-5D-3L and EQ-5D-5L are two generic health-related quality of life
measures, which may be used in clinical and health economic research. They measure …

Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy

A Bhadhuri, P Kind, P Salari, KT Jungo… - Health and Quality of …, 2020 - zora.uzh.ch
BACKGROUND The EQ-5D-3L and EQ-5D-5L are two generic health-related quality of life
measures, which may be used in clinical and health economic research. They measure …

Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy.

A Bhadhuri, P Kind, P Salari, KT Jungo… - Health and quality of life …, 2020 - sonar.ch
METHODS Between 2017 and 2019, we administered EQ-5D-3L and EQ-5D-5L to a subset
of patients participating in the OPERAM trial at 6 months and 12 months after enrolment. The …